3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase
about
Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalphaWhy Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesionmTORC2 is required for proliferation and survival of TSC2-null cells.High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase.Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression.Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndromeActivated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expressionAtorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men.Combinatorial regulation of lipoprotein lipase by microRNAs during mouse adipogenesis.A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists.Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients.Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent.Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus.
P2860
Q24290442-1D092CD6-1B65-4E77-97E2-6ADE30F6A3A7Q28077776-53636573-0C89-4B38-8276-48EC25EA41B6Q30536352-43611908-C8C8-4F79-819B-239AD71388E2Q34177457-8878F850-1204-4003-8A01-437C78C2BC62Q35048736-5608411B-AB3A-4A99-8837-EB38A68A127AQ36044934-306320BA-0719-4EB3-9524-3A62CB7D046AQ36296953-406138F1-FBF0-47E4-B828-D70D51D984C6Q36807515-E6843865-F646-40A7-BBEE-EC607931D9AFQ37214684-04872991-D35C-40FF-923B-D2E291806E77Q37326019-58E4A7A4-5448-4A1A-9684-DBD959FA2E13Q37413198-238098BF-5501-41BC-B922-27C5BA67425DQ37593662-7A7BC98E-9172-4DEE-806D-8EC5B2C1543FQ41063014-48E3D0C6-FA21-4E0F-AA84-835E555515ADQ42804566-D404F27E-D32A-4ED4-B374-43EA5DBBC300Q44387520-1524E985-77D9-428D-8A0A-59CDD6633AADQ44605265-812A530F-A406-4184-B212-C03DF7E60520Q44627507-07AA2DD0-22D0-4969-99F9-70A21B969F56Q45037103-58742D61-EF1F-4147-9154-D30CF3EECBA4Q45993814-4675F909-C1E4-455F-ABF6-16C4001D55FDQ46781809-F238644A-971F-43A8-8B3B-3F7BA0816EE8
P2860
3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase
description
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Juni 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/06/11)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/06/11)
@nl
наукова стаття, опублікована в червні 1999
@uk
مقالة علمية (نشرت في 11-6-1999)
@ar
name
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@ast
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@en
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@nl
type
label
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@ast
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@en
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@nl
prefLabel
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@ast
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@en
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@nl
P2093
P2860
P3181
P1433
P1476
3-Hydroxy-3-methylglutaryl CoA ...... n C-III and lipoprotein lipase
@en
P2093
A. Tailleux
J. C. Fruchart
K. Schoonjans
P2860
P304
P3181
P356
10.1016/S0014-5793(99)00632-8
P407
P577
1999-06-11T00:00:00Z